Sort
16,300 grants matching “fatty liver disease”
Melamine/Cyanuric Acid Exposure and Kidney Injury in Children
$225,000Sheela Sathyanarayana · Seattle Children'S Hospital · R21 · FY2019 · ES
Clinically suitable approach for gene-mediated therapy of cirrhosis.
$224,999Estuardo Aguilar-Cordova · Advantagene, Inc · R43 · FY2014 · AA
Human on a chip systems to investigate disease comorbidities common in the aged population
$224,999Michael L Shuler · Hesperos, Llc · R44 · FY2018 · AG
Human on a chip systems to investigate disease comorbidities common in the aged population
$224,999Michael L Shuler · Hesperos, Llc · R44 · FY2019 · AG
Clincal Research Network in Non-Alcoholic Steatohepatitis (NASH CRN)
$224,985Arthur J McCullough · Cleveland Clinic Lerner Com-Cwru · U01 · FY2013 · DK
Screening for Alcohol-Related Liver Disease Using Breath Signatures by DMS
$224,983Royce W Johnson · Applied Nanotech, Inc. · R43 · FY2014 · AA
Pharmacological evaluation of MLR-1023: Studies to confirm efficacy, establish a
$224,981Andrew Gerard Reaume · Melior Discovery, Inc. · R43 · FY2014 · DK
FABP4 Released from Steatotic Hepatocytes in Alcoholic Liver Disease Enhances Hepatic Tumor Progression
$224,969Iain Hugh McKillop · Carolinas Medical Center · R21 · FY2021 · AA
Role of urolithin A in progression of alcohol-associated liver disease
$224,969Venkatakrishna R Jala · University Of Louisville · R21 · FY2023 · AA
Lipid Binding Proteins in Obesity and Diabetes Syndromes
$224,945David A Bernlohr · University Of Minnesota · R56 · FY2017 · DK
Furan fatty acids (FuFAs) as the active components of fish oils and omega-3 fatty acid products
$224,944Fei Chang · Furanica, Inc. · R43 · FY2018 · AT
CONTROL OF GENE TRANSCRIPTION BY ESSENTIAL FATTY ACIDS
$224,845University Of Texas Austin · R01 · FY2001 · DK
Effect of dietary fat on the hepatotoxicity of environmental arsenic
$224,750Walter H Watson · University Of Louisville · R21 · FY2012 · ES
Community Engagement Core
$224,717Dwayne Edward Porter · University Of South Carolina At Columbia · P01 · FY2021 · ES
Adipokine Secretion Enhancer Synthetic Organic Drug Discovery in Human Adipocytes
$224,700Eric Clinton Seales · Discoverybiomed, Inc. · R43 · FY2013 · DK
Noninvasive urinary monitoring of NASH by activity-based nanosensors
$224,659Eric Kai Huang · Glympse Bio, Inc. · R44 · FY2017 · DK
Nonalcoholic Steatohepatitis Therapies from the Ubiquitin Pathway
$224,618David E Sterner · Progenra, Inc. · R43 · FY2019 · DK
Fatty Acid Binding Protein and Pathological Retinal Vascularization
$224,600Sule Cataltepe · Brigham And Women'S Hospital · R21 · FY2012 · EY
Translational Core
$224,511Teresa L. Wright · Rockefeller University · U19 · FY2009 · AI
Discovery next generation inhibitors of ALDH2 to reduce craving and alcohol consumption in alcohol use disorders
$224,500Brent Keith Blackburn · Amygdala Neurosciences, Inc. · R43 · FY2021 · AA
Project 10 - The role of nanoformulated Cu/ZnSOD in reducing systemic hypertensi
$224,465Saraswathi Viswanathan · University Of Nebraska Medical Center · P20 · FY2013 · GM
Clinical Research Network in Non Alcoholic Steatohepatitis
$224,394Kris Kowdley · Benaroya Research Inst At Virginia Mason · U01 · FY2007 · DK
PLIN2, VLDL Biogenesis and Lipid Homeostasis
$224,296Benny Hung-Junn Chang · Baylor College Of Medicine · R01 · FY2013 · DK
Alcohol-induced lung lipid changes contribute to development of acute lung injury
$224,250Ross S Summer · Thomas Jefferson University · R21 · FY2015 · AA
Role of sirtuin 6 in the protection of liver from the alcohol-induced injury
$224,250Xiaocheng Charlie Dong · Indiana University Indianapolis · R21 · FY2017 · AA